Información:
Error:
ID
14821
Descripción
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01625286
Link
https://clinicaltrials.gov/show/NCT01625286
Palabras clave
Versiones (1)
- 29/4/16 29/4/16 -
Subido en
29 de abril de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
- StudyEvent: Eligibility
Similar models
Eligibility Advanced or Metastatic Breast Cancer, NCT01625286
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
female patient
Item
female patient
boolean
C0150905 (UMLS CUI [1])
age
Item
aged at least 18 years
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
histological or cytological confirmation of breast cancer with evidence of advanced or metastatic disease (must be er+ve, her2-ve, in part b).
boolean
C0678222 (UMLS CUI [1])
who performance status
Item
world health organisation (who) performance status 0-1 with no deterioration over the previous 2 weeks and minimum life expectancy of 12 weeks.
boolean
C1298650 (UMLS CUI [1])
clinically significant abnormalities of glucose metabolism
Item
clinically significant abnormalities of glucose metabolism
boolean
C0744434 (UMLS CUI [1])
spinal cord compression
Item
spinal cord compression or brain metastases unless asymptomatic, treated and stable (not requiring steroids).
boolean
C0037926 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0220650 (UMLS CUI [2])
systemic diseases, bleeding diatheses
Item
evidence of severe or uncontrolled systemic diseases, including active bleeding diatheses or active infections including hepatitis b, c and hiv.
boolean
C1536063 (UMLS CUI [1])
C0442893 (UMLS CUI [2])
C0442893 (UMLS CUI [2])
inhibit akt
Item
any prior exposure to agents which inhibit akt as the primary pharmacological activity.
boolean
C0812228 (UMLS CUI [1])
chemotherapy
Item
part a: more than two prior courses of chemotherapy (including taxanes) for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1])
chemotherapy
Item
part b: any prior chemotherapy for advanced or metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0278488 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,2])